University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms : FUTURE, a superiority RCT and economic evaluation

Simple item page
dc.contributor.authorAbdel-Fattah, Mohamed
dc.contributor.authorChapple, Christopher
dc.contributor.authorBreeman, Suzanne
dc.contributor.authorCooper, David
dc.contributor.authorBell-Gorrod, Helen
dc.contributor.authorKuppanda, Preksha
dc.contributor.authorGuerrero, Karen L.
dc.contributor.authorDixon, Simon
dc.contributor.authorCotterill, Nikki
dc.contributor.authorWard, Karen
dc.contributor.authorHashim, Hashim
dc.contributor.authorMonga, Ash
dc.contributor.authorBrown, Karen
dc.contributor.authorDrake, Marcus
dc.contributor.authorGammie, Andrew
dc.contributor.authorMostafa, Alyaa
dc.contributor.authorBruce, Rebecca
dc.contributor.authorBell, Victoria
dc.contributor.authorKennedy, Christine
dc.contributor.authorEvans, Suzanne
dc.contributor.authorMacLennan, Graeme
dc.contributor.authorNorrie, John
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Women’s Health Researchen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Evaluationen
dc.contributor.institutionUniversity of Aberdeen.Centre for Healthcare Randomised Trials (CHaRT)en
dc.contributor.institutionUniversity of Aberdeen.Medical Educationen
dc.date.accessioned2025-07-18T08:48:01Z
dc.date.available2025-07-18T08:48:01Z
dc.date.issued2025-07-01
dc.descriptionThe authors want to thank all the women who participated in the FUTURE trial. We also thank: the CHaRT data co-ordinators (Louise Campbell and Dianne Dejean), assistant trial managers (Zoe Batham, Karlee Dyck, Gillian Ferry, Elerita Flammini and Guilia Uitenbosch) and trial manager (Tracey Davidson) for their data/trial management support; senior members of the CHaRT team for their support throughout the study (Graeme MacLennan (Director), Alison McDonald (Senior Trials Manager until December 2020), Seonaidh Cotton (Senior Trials Manager from May 2021), Ruth Thomas (CHaRT Research Manager) and Samantha Wileman (Quality Assurance Manager)); the CHaRT programming team, led by Mark Forrest, for developing and maintaining the trial website; staff members who have contributed to the economic data collection and analysis (Abualbishr Alshreef) and modelling and value-of-information analysis (Praveen Thokala); Megan Pardoe, who contributed to the qualitative component of the trial until December 2021; Juliette Snow and Rachael West for their support with contracting requirements between academic institutions and research sites; the Research Governance team at the University of Aberdeen for their advice and support during the study (Louise King, Stacey Dawson, Lynn McKay); members of the project management group for their ongoing advice and support, the independent members of the Trial Steering Committee and Data Monitoring Committee and the staff at the recruitment sites who facilitated the recruitment, treatment and follow-up of trial participants (all listed below). Finally, we would like to thank the NIHR and the HTA Programme for funding the FUTURE trial and for the generous continuation of funding for longer-term follow-up. Suzanne Evans (Bladder Health UK, PPI) has been involved as a PPI team member since conception of the trial, oversaw the conduct of the trial and the interpretation of results and the writing/editing of the report.en
dc.description.statusPeer revieweden
dc.format.extent164
dc.format.extent2542457
dc.identifier305889172
dc.identifiera1b27933-0c5f-4345-b67b-cc1598e52f35
dc.identifier105010662905
dc.identifier40620147
dc.identifier.citationAbdel-Fattah, M, Chapple, C, Breeman, S, Cooper, D, Bell-Gorrod, H, Kuppanda, P, Guerrero, K L, Dixon, S, Cotterill, N, Ward, K, Hashim, H, Monga, A, Brown, K, Drake, M, Gammie, A, Mostafa, A, Bruce, R, Bell, V, Kennedy, C, Evans, S, MacLennan, G & Norrie, J 2025, 'Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms : FUTURE, a superiority RCT and economic evaluation', Health Technology Assessment, vol. 29, no. 27. https://doi.org/10.3310/UKYW4923en
dc.identifier.doi10.3310/UKYW4923
dc.identifier.iss27en
dc.identifier.issn1366-5278
dc.identifier.otherRIS: urn:90599D54DFAC2A49A0894F25F6AC5F6F
dc.identifier.otherORCID: /0000-0002-1039-5646/work/188340410
dc.identifier.urihttps://hdl.handle.net/2164/25725
dc.identifier.vol29en
dc.language.isoeng
dc.relation.ispartofHealth Technology Assessmenten
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicine (General)en
dc.subjectSupplementary Dataen
dc.subjectDASen
dc.subjectSupplementary Informationen
dc.subject.lccR1en
dc.titleInvasive urodynamic investigations in the management of women with refractory overactive bladder symptoms : FUTURE, a superiority RCT and economic evaluationen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Abdel-Fattah_etal_HTA_Invasive_Urodynamic_Investigations_VOR.pdf
Size:
2.42 MB
Format:
Adobe Portable Document Format
Download

Collections

All research